The global hybrid imaging market size is expected to reach USD 11.95 billion by 2030, according to a new report by Grand View Research, Inc., registering a 6.1% CAGR from 2024 to 2030. Increasing demand for accurate diagnostic techniques for cancer and cardiac disorders is expected to drive the market. Rising government initiatives for creating awareness regarding multimodal imaging devices are also expected to contribute toward market growth.
Increasing installation of such devices in research centers and institutions to enhance diagnostics in the field of oncology, cardiology, neurology, and others is expected to boost market growth. Leading players in the market are showcasing various multimodal imaging devices at medical conferences to increase their product reach. However, high cost and complications associated with these devices is expected to impede market growth during the forecast period.
Hybrid imaging devices require skilled professionals to understand the data collected by these combined devices. Therefore, various training programmes are conducted by several non-profit and government funded organizations to increase the adoption of hybrid imaging devices for the diagnosis of a disease.
North America dominated the hybrid/multimodal imaging market in 2018 and is expected to grow at a significant rate during the forecast period. The growth observed in this region is largely due to presence of global players and increasing adoption of advanced equipment such as hybrid imaging devices. Moreover, increasing awareness regarding nuclear medicine and molecular diagnostics in the region is expected to contribute toward the growth in this region.
Asia Pacific is expected register the strongest growth over the forecast period. This can be primarily attributed to growing usage of advanced devices such as PET/CT systems in radiology departments across emerging economies. Thriving medical tourism in numerous countries has piqued the interest of global market players, who are looking to invest in the development and launch of advanced software in the region. The Europe market is fueled by ongoing efforts by various non-profit organizations in conducting educational and training programs for scientists, physicians, technologists, physicists, radiographers, and others in the field.
Request a free sample copy or view report summary: Hybrid Imaging Market Market Report
The PET/CT systems segment accounted for the largest market share of 32.3% in 2023. Technical advancements in PET imaging for advanced diagnostics applications and oncology and rising demand for PET analysis in radiopharmaceuticals are expected to drive market growth.
The oncology segment accounted for the largest market share of 39.2% in 2023 and is expected to grow at the fastest CAGR over the projected period.
Hospitals dominated the market with 53.5% of the revenue share in 2023. The market growth is anticipated to receive a significant boost from the increased adoption of new and advanced MRI systems by end-users.
North America hybrid imaging market dominated the global market and accounted for 42.0% revenue share in 2023.
Grand View Research has segmented the global hybrid imaging market on the basis of type, application, end use, and region:
Hybrid Imaging Type Outlook (Revenue, USD Million, 2018 - 2030)
PET/CT systems
SPET/CT systems
PET/MR systems
OCT/Fundus Imaging System
Others
Hybrid Imaging Application Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Ophthalmology
Cardiology
Brain & Neurology
Others
Hybrid Imaging End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Imaging Centers
Others
Hybrid Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Hybrid Imaging Market
GE HealthCare
Siemens Healthcare
Koninklijke Philips N.V.
CANON MEDICAL SYSTEMS CORPORATION
Shanghai United Imaging Healthcare Co., LTD
TTG IMAGING SOLUTIONS (Digirad)
Carl Zeiss Meditec AG
Topcon Corporation
Heidelberg Engineering
NIDEK
"The quality of research they have done for us has been excellent..."